These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29740203)

  • 1. Olfactomedin-4 in digestive diseases: A mini-review.
    Wang XY; Chen SH; Zhang YN; Xu CF
    World J Gastroenterol; 2018 May; 24(17):1881-1887. PubMed ID: 29740203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactomedin 4 expression and functions in innate immunity, inflammation, and cancer.
    Liu W; Rodgers GP
    Cancer Metastasis Rev; 2016 Jun; 35(2):201-12. PubMed ID: 27178440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection.
    Liu W; Yan M; Liu Y; Wang R; Li C; Deng C; Singh A; Coleman WG; Rodgers GP
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11056-61. PubMed ID: 20534456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers.
    Yu L; Wang L; Chen S
    Neoplasma; 2011; 58(1):9-13. PubMed ID: 21067260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway.
    Li H; Liu W; Chen W; Zhu J; Deng CX; Rodgers GP
    Sci Rep; 2015 Nov; 5():16974. PubMed ID: 26581960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer.
    Li H; Kim C; Liu W; Zhu J; Chin K; Rodriguez-Canales J; Rodgers GP
    Int J Cancer; 2020 Mar; 146(5):1346-1358. PubMed ID: 31241767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling.
    Guo LL; He ZC; Yang CQ; Qiao PT; Yin GL
    BMB Rep; 2015 Nov; 48(11):630-5. PubMed ID: 26303970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer.
    Jang BG; Lee BL; Kim WH
    Virchows Arch; 2015 Sep; 467(3):285-94. PubMed ID: 26070873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients.
    Oue N; Sentani K; Noguchi T; Ohara S; Sakamoto N; Hayashi T; Anami K; Motoshita J; Ito M; Tanaka S; Yoshida K; Yasui W
    Int J Cancer; 2009 Nov; 125(10):2383-92. PubMed ID: 19670418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
    Jaitner S; Pretzsch E; Neumann J; Schäffauer A; Schiemann M; Angele M; Kumbrink J; Schwitalla S; Greten FR; Brandl L; Klauschen F; Horst D; Kirchner T; Jung A
    J Pathol Clin Res; 2023 Jan; 9(1):73-85. PubMed ID: 36349502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
    Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
    Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
    Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
    J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells.
    Liu RH; Yang MH; Xiang H; Bao LM; Yang HA; Yue LW; Jiang X; Ang N; Wu LY; Huang Y
    J Biomed Sci; 2012 Apr; 19(1):38. PubMed ID: 22471589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of olfactomedin 4 correlates with poor prognosis in smoking patients with non-small cell lung cancer.
    Su W; Luo L; Wu F; Lai Z; Li X; Xie Z; Tang Z; Yang Z; Liang R
    Hum Pathol; 2015 May; 46(5):732-8. PubMed ID: 25771901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactomedin-4 improves cutaneous wound healing by promoting skin cell proliferation and migration through POU5F1/OCT4 and ESR1 signalling cascades.
    Klaas M; Mäemets-Allas K; Heinmäe E; Lagus H; Arak T; Eller M; Kingo K; Kankuri E; Jaks V
    Cell Mol Life Sci; 2022 Feb; 79(3):157. PubMed ID: 35218417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor.
    Chin KL; Aerbajinai W; Zhu J; Drew L; Chen L; Liu W; Rodgers GP
    Br J Haematol; 2008 Nov; 143(3):421-32. PubMed ID: 18764868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis.
    Koshida S; Kobayashi D; Moriai R; Tsuji N; Watanabe N
    Cancer Sci; 2007 Mar; 98(3):315-20. PubMed ID: 17270020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
    Ohkuma R; Yada E; Ishikawa S; Komura D; Ishizaki H; Tamada K; Kubota Y; Hamada K; Ishida H; Hirasawa Y; Ariizumi H; Satoh E; Shida M; Watanabe M; Onoue R; Ando K; Tsurutani J; Yoshimura K; Yokobori T; Sasada T; Aoki T; Murakami M; Norose T; Ohike N; Takimoto M; Izumizaki M; Kobayashi S; Tsunoda T; Wada S
    PLoS One; 2020; 15(1):e0226707. PubMed ID: 31923206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Luo Z; Zhang Q; Zhao Z; Li B; Chen J; Wang Y
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1713-20. PubMed ID: 21904905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactomedin-4 is a candidate biomarker of solid gastric, colorectal, pancreatic, head and neck, and prostate cancers.
    Guette C; Valo I; Vétillard A; Coqueret O
    Proteomics Clin Appl; 2015 Feb; 9(1-2):58-63. PubMed ID: 25400027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.